Showing 161 - 180 results of 395 for search '"Pharmaceutics"', query time: 0.05s Refine Results
  1. 161
  2. 162

    Comparison of clinical and pharmacodynamic features of proton pump inhibitors efficacy in gastroesophageal reflux disease by O. A. Storonova, A. S. Trukhmanov

    Published 2015-12-01
    “…PPI are the most effective pharmaceuticals for treatment of acid-related diseases (ARD). …”
    Get full text
    Article
  3. 163

    Alcohol, alcoholism and related consequences by M. V. Mayevskaya

    Published 2013-12-01
    “…Successful campaign against alcoholism is possible only at application of all resources: strategy of the state, involvement of internist doctors in problem decision (application of motivational conversation technic), pharmaceutical therapy directed on reduction of amount alcoholic drinks.…”
    Get full text
    Article
  4. 164
  5. 165

    Drug-induced liver injuries (Part 1) by S. F. Galimova

    Published 2012-06-01
    “…DILI can progress under the mask of all known acute and chronic liver diseases. Pharmaceuticals act as one of the leading causes of development of fulminant liver failure in many countries of the world. …”
    Get full text
    Article
  6. 166

    Efficacy of silymarinum at chronic diffuse liver diseases by A. V. Matvieiev, E. I. Konyaeva, N. V. Matvieieva

    Published 2011-09-01
    “…Analysis of literary data demonstrated, that silymarinum is a safe pharmaceutical and, despite of a plenty of clinical and experimental publications, its efficacy at alcoholic liver disease and primary biliary cirrhosis requires further studying as series of systematic reviews and metaanalyses are subject for discussion due to the absence of uniform methodological approaches, application of drugs with different pharmakokinetics and because of ignoring of evidencebased medicine requirements.Conclusion. …”
    Get full text
    Article
  7. 167

    Metabolomic profiles as a new understanding of disease processes by O. Yu. Zolnikova, M. S. Reshetova, M. N. Ivanova, V. T. Ivashkin

    Published 2022-05-01
    “…These results define new potential therapeutic strategies, making metabolomics useful for a wide range of biomedical and pharmaceutical research.Conclusion. Metabolomic profile changes in different types of diseases will help to improve understanding of the pathogenesis. …”
    Get full text
    Article
  8. 168

    A clinical study on the efficacy and safety of poly-herbal formulation in managing functional dyspepsia by Debasish Hota, Anand Srinivasan, Manas Kumar Panigrahi, Snigdha Suman Dalua, Poorva Tiwari, Ramachandran Valavan

    Published 2025-02-01
    “…While there are several pharmaceutical treatments available, many individuals are turning to herbal remedies as a safer and more natural alternative. …”
    Get full text
    Article
  9. 169
  10. 170
  11. 171

    Leading causes of fever in patients with liver function disorders by V. T. Ivashkin, M. A. Morozova, M. V. Mayevskaya

    Published 2010-02-01
    “…If the site of infection is not detected, it is necessary to keep in mind the option of development of non-infectious fever within acute phase reaction, neoplastic process or reaction to applied pharmaceutical agents.Conclusion. At development of fever at patients with liver failure carrying out differential diagnostics of the causes of body temperature elevation is necessary that allows more differentiated approaches to treatment.…”
    Get full text
    Article
  12. 172

    How to improve psychiatric nosography in the XXI century: a phenomenologist”s viewpoint by Giovanni Stanghellini

    Published 2025-01-01
    “…Classifications of mental disorders reflect much more the minds of psychiatrists than the patients’ minds since these classifications are more focused on the interests of stakeholders (including governmental agencies, advocacy groups, medical insurance, and pharmaceutical companies) than on the experiences of patients. …”
    Get full text
    Article
  13. 173

    One size fits all: Enhanced zero-shot text classification for patient listening on social media by Veton Matoshi, Maria Carmela De Vuono, Roberto Gaspari, Mark Kröll, Michael Jantscher, Sara Lucia Nicolardi, Giuseppe Mazzola, Manuela Rauch, Vedran Sabol, Eileen Salhofer, Riccardo Mariani

    Published 2025-02-01
    “…Patient-focused drug development (PFDD) represents a transformative approach that is reshaping the pharmaceutical landscape by centering on patients throughout the drug development process. …”
    Get full text
    Article
  14. 174

    Changes of the colon and rational choice of drug for treatment of chronic constipation in senile patients by S. G. Burkov, E. V. Kasimtseva, L. Yu. Agafonova

    Published 2015-03-01
    “…Lactulose (Duphalac) is an optimal pharmaceutical with high efficacy.…”
    Get full text
    Article
  15. 175

    Acetylcholine in irritable bowel syndrome pathogenesis and the role of cholineblockers by Yu. O. Shulpekova

    Published 2011-02-01
    “…The agents, influencing cholinergic receptors, are one of basic resources of modern pharmaceutical therapy of irritable bowel syndrome.…”
    Get full text
    Article
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180